RepliCel Life Sciences Inc (OTCQB:REPCF)

0.47
Delayed Data
As of Mar 27
 +0.0753 / +19.08%
Today’s Change
0.26
Today|||52-Week Range
0.74
+45.06%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2013
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization2.2K1.4K1.7K1.8K
 
 
 
 
 
 
Operating ExpensesGross Income-2.2K-1.4K-1.7K-1.8K
 
 
 
 
 
General Expenses1.1M1.1M1.3M1.2M
 
 
 
 
 
Research And Development720.8K415.2K337.6K491.5K
 
 
 
 
 
Total Operating Expenses1.1M1.1M1.3M1.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-1.1M-1.1M-1.3M-1.2M
 
 
 
 
 
Extraordinary Credit100.1K----15.3K
 
 
 
Extraordinary Charge0.00-4.4K-26.2K--
 
 
 
Other Expenses-3.5K-6.9K-14.8K17.9K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-992.8K-1.1M-1.3M-1.1M
 
 
 
 
 
Net Income-992.8K-1.1M-1.3M-1.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS48.1M46.6M50.6M53.2M
 
 
 
 
 
Shares To Calculate EPS Diluted48.1M46.6M50.6M53.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.02-$0.03-$0.03-$0.02
 
 
 
 
 
EPS Diluted-$0.02-$0.03-$0.03-$0.02
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account